Global clinical testing specialist to build European laboratory hub in UK
Quotient Bioresearch, a leading UK provider of drug development services, and Clinical Reference Laboratory (CRL), a privately owned reference laboratory based in Kansas, US are to provide a global clinical laboratory testing capability in the UK to support their clients worldwide.
Quotient Bioresearch, a leading UK provider of drug development services, and Clinical Reference Laboratory (CRL), a privately owned reference laboratory based in Kansas, US are to provide a global clinical laboratory testing capability in the UK to support their clients worldwide.
Under the agreement, CRL Global Services will set up its European clinical reference laboratory operation within Quotient's state-of-the-art facility in Cambridgeshire, UK, establishing it as the European hub for its Central Laboratory Services unit. This will complement Quotient's existing clinical laboratory services, particularly in the areas of bioanalysis and biomarkers.
Quotient and CRL Global Services will jointly offer clinical laboratory and other specialist testing services to the pharmaceutical, biotechnology and CRO industries.
Paul Cowan, chief executive of Quotient Bioresearch, said: "This collaboration brings exciting new opportunities for our bioanalytical sciences and microbiology businesses. Working in tandem with CRL offers access to a well established, standardised global laboratory infrastructure and the ability to serve the requirements of our clients for global clinical trials."
Rajani Prasad, vice president, clinical trials and Arnold Verbeek, general manager of Clinical Reference Laboratory - Europe, added: "Our agreement with Quotient Bioresearch signals a new chapter in CRL's development. We are confident that by using our own operations and applying our technology on a global scale CRL guarantees clients the most streamlined, highest quality and best value available in clinical trials support."
